Sandro Pignata

Sandro Pignata

UNVERIFIED PROFILE

Are you Sandro Pignata?   Register this Author

Register author
Sandro Pignata

Sandro Pignata

Publications by authors named "Sandro Pignata"

Are you Sandro Pignata?   Register this Author

100Publications

3083Reads

31Profile Views

Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for Testing.

J Clin Oncol 2020 Jan 7;38(2):172-173. Epub 2019 Nov 7.

Alberto Farolfi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola, Italy; Domenica Lorusso, MD, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Sandro Pignata, MD, PhD, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy; and Ugo De Giorgi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02055DOI Listing
January 2020

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

N Engl J Med 2019 12;381(25):2416-2428

From Centre Léon Bérard (I.R.-C., D.P.), University Claude Bernard Lyon 1 (I.R.-C.), and Centre Hospitalier Lyon-Sud (B.Y.), Lyon, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) (I.R.-C., P.P., F.S., C.L.-P., A.L., P.C., M.R., C.D., B.Y., E.P.-L.), Groupe Hospitalier Diaconesses Croix Saint-Simon (F.S.), Hôpital Européen Georges Pompidou (P.C.), Institut Curie, Hôpital Claudius Régaud (M.R.), and Association de Recherche Cancers Gynécologiques (ARCAGY) (E.P.-L.), Paris, Gustave Roussy, Villejuif (P.P.), Centre Eugène Marquis, Rennes (C.L.-P.), Centre Catherine de Sienne Hôpital Privé du Confluent, Nantes (A.L.), and Institut Curie, Hôpital René Huguenin, Saint Cloud (C.D.) - all in France; the Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples (S.P.), University of Milan-Bicocca and European Institute of Oncology IRCCS, and Mario Negri Gynecologic Oncology Group (MANGO) (N.C.), and Fondazione IRCCS Istituto Nazionale Tumori and MITO (D.L.), Milan, and Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, and MITO, Rome (G.S.) - all in Italy; M.D. Anderson Cancer Center Madrid (A.G.-M.), Grupo Español de Investigación en Cáncer de Ovario (GEICO) (A.G.-M., E.M.G.A.), and Hospital Universitario Ramón y Cajal (E.M.G.A.) - all in Madrid; Medical University of Innsbruck, University Clinic for Gynecology and Obstetrics (R.B.), and Arbeitsgemeinschaft Gynäkologische Onkologie Study Group (AGO)-Austria (R.B., A.R.), Innsbruck, and Medical University of Vienna, Vienna (A.R.) - all in Austria; Saitama Medical University International Medical Center, Hidaka (K.F.), Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Moroyama-cho (K.F., S.N.), and Hyogo Cancer Center, Akashi (S.N.) - all in Japan; University Hospital Leuven, Leuven Cancer Institute, and Belgium and Luxembourg Gynecologic Oncology Group (BGOG) - both in Leuven, Belgium (I.V.); Tampere University and University Hospital, Tampere, Finland (J.M.); the Nordic Society of Gynecologic Oncology (NSGO), Copenhagen (J.M.); and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin (J.S.), German Society of Gynecologic Oncology (AGO) (J.S., U.C., F.M., N.G., P.B., A.B., P.H.), Universitätsklinikum Essen (P.B.), and Kliniken Essen Mitte (P.H.), Essen, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden (U.C.), Universitätsklinikum Heidelberg, Heidelberg (F.M.), Universitätsklinikum Ulm, Ulm (N.G.), and Klinikum der Universität München, Munich (A.B.) - all in Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1911361DOI Listing
December 2019

Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors.

Cancers (Basel) 2019 Oct 17;11(10). Epub 2019 Oct 17.

Department of Obstetrics and Gynaecology, San Raffaele Scientific Institute, 20132 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11101584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826947PMC
October 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners.

Int J Gynecol Cancer 2019 09 18;29(7):1094-1097. Epub 2019 Jul 18.

GOG-F and Gynecologic Oncology, Ohio State University Wexner Medical Center and JamesCare Gynecologic Oncology at Mill Run, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://ijgc.bmj.com/lookup/doi/10.1136/ijgc-2019-000441
Publisher Site
http://dx.doi.org/10.1136/ijgc-2019-000441DOI Listing
September 2019

Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives.

J Clin Oncol 2019 Sep 12;37(27):2437-2448. Epub 2019 Aug 12.

Istituto Nazionale Tumori Fondazione G Pascale, Istituto di Ricovero e Cura a Carattere Scientifico, Napoli, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00194DOI Listing
September 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners.

Gynecol Oncol 2019 08;154(2):255-258

GOG-F and Gynecologic Oncology, Ohio State University Wexner Medical Center and JamesCare Gynecologic Oncology at Mill Run, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.04.677DOI Listing
August 2019

Obesity and Cancer: Biological Links and Treatment Implications.

Curr Cancer Drug Targets 2018 ;18(3):231-238

Istituto Nazionale Tumori di Napoli, "G. Pascale" foundation, Department of Abdominal Oncology, via M. Semmola, 80131, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009617666170330125619DOI Listing
April 2019

PARP inhibitors in ovarian cancer.

Cancer Treat Rev 2019 Feb 4;73:1-9. Epub 2018 Dec 4.

Division of Medical Oncology, Department of Precision Medicine, School of Medicine, "Luigi Vanvitelli" University of Campania, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183020
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.12.002DOI Listing
February 2019

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.

J Clin Oncol 2018 05 20;36(13):1300-1307. Epub 2018 Mar 20.

Nicoletta Colombo, University of Milan-Bicocca; Nicoletta Colombo, Istituto Europeo di Oncologia, Milan; Giovanni Scambia, Università Cattolica del Sacro Cuore di Roma, Rome; Sandro Pignata, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G Pascale IRCCS, Naples, Italy; Gloria Huang, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx; Eva Chalas, Winthrop University Hospital, Mineola, NY; James Fiorica, Sarasota Memorial Hospital, Sarasota, FL; Linda Van Le, University of North Carolina School of Medicine, Chapel Hill, NC; Sharad Ghamande, The Georgia Cancer Center at Augusta University, Augusta; Andrew Green, Northeast Georgia Medical Center, Gainesville, GA; Santiago González-Santiago, Hospital San Pedro de Alcántara, Cáceres; Isabel Bover, Hospital Son Llàtzer, Palma; Begoña Graña Suárez, University Hospital A Coruña, Sergas, Spain; Philippe Huot-Marchand and Yann Bourhis, Mapi Real World Evidence, Lyon, France; Sudeep Karve, AstraZeneca, Gaithersburg, MD; and Christopher Blakeley, AstraZeneca, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.2781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804908PMC
May 2018

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.

J Clin Oncol 2017 Oct 21;35(29):3347-3353. Epub 2017 Aug 21.

Sandro Pignata, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Laura Arenare, Alice Bergamini, Jane Bryce, Gennaro Daniele, Maria Carmela Piccirillo, and Francesco Perrone, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione G. Pascale, IRCCS; Simona Signoriello and Ciro Gallo, Università degli Studi della Campania Luigi Vanvitelli, Naples; Giovanni Scambia, Domenica Lorusso, Gabriella Ferrandina, and Vanda Salutari, Università Cattolica del Sacro Cuore; Enrico Breda, Ospedale San Giovanni Calibita Fatebenefratelli, Rome; Alessandra Bologna, Azienda Ospedaliea Santa Maria Nuova, IRCCS, Reggio Emilia; Domenica Lorusso and Francesco Raspagliesi, Fondazione IRCCS Istituto Nazionale dei Tumori; Giorgia Mangili and Alice Bergamini, Ospedale San Raffaele, Milan; Viviana Murgia, Ospedale Santa Chiara, Trento; Roberto Sorio, Centro di Riferimento Oncologico, Aviano; Gabriella Ferrandina, Centro di Ricerca e Formazione Ad Alta Tecnologia nelle Scienze Biomediche, Università Cattolica del Sacro Cuore, Campobasso; Cosimo Sacco, Azienda Ospedaliera di Perugia Santa Maria della Misericordia, Udine; Gennaro Cormio, Ginecologia Oncologica, Università di Bari e Istituto Oncologico "Giovanni Paolo II" Bari; Saverio Cinieri, Ospedale Antonio Perrino, Brindisi; Donato Natale, Ospedale San Massimo, Penne, Italy; Ignace B. Vergote, University Hospital Leuven and Belgian and Luxembourg Gynaecological Oncology Group, Leuven Cancer Institute, Leuven, Belgium; and Uwe Wagner, Uniklinkum Giessen und Marburg Gynäkologie, Marburg, Germany.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.4293
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.4293DOI Listing
October 2017

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.

J Transl Med 2017 10 11;15(1):205. Epub 2017 Oct 11.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-017-1309-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637331PMC
October 2017

Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.

Cancer Treat Rev 2017 Sep 31;59:109-116. Epub 2017 Jul 31.

Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372173012
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2017.07.008DOI Listing
September 2017

Emesis and nausea related to single agent trabectedin in ovarian cancer patients: a sub-study of the MITO15 project.

Support Care Cancer 2017 06 19;25(6):1743-1748. Epub 2017 Jan 19.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Via Mariano Semmola, 52, 80131, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3547-xDOI Listing
June 2017

Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.

Anticancer Drugs 2017 01;28(1):104-109

aDivision of Medical Oncology, Department of Uro-Gynaecological Oncology 'Istituto Nazionale Tumori' 'Fondazione G. Pascale'-IRCCS bUnit of Epidemiology, 'Istituto Nazionale Tumori' 'Fondazione G. Pascale' - IRCCS cDivision of Medical Oncology, 'San Gennaro dei Poveri' Hospital, Naples dDepartment of Onco-Ematology and Medical Oncology, S.G. Moscati Hospital of Taranto, Taranto eDivision of Medical Oncology, 'San Giuseppe Moscati' Hospital, Avellino fDivision of Medical Oncology, 'Gaetano Rummo' Hospital, Benevento gDepartment of Medical Oncology, National Cancer Institute, Aviano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000428DOI Listing
January 2017

A miRNA signature assessing ovarian cancer prognosis.

Oncoscience 2016 2;3(11-12):308-310. Epub 2016 Dec 2.

Molecular Therapies Unit, Dept of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5235915PMC
December 2016

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

J Clin Oncol 2016 08 11;34(24):2881-7. Epub 2016 Jul 11.

Toru Sugiyama, Iwate Medical University, Iwate; Aikou Okamoto, Hiroshi Tanabe, and Seiji Isonishi, The Jikei University School of Medicine; Tetsutaro Hamano, Kitasato University; Yasuhisa Terao, Juntendo University; Mikio Mikami, Tokai University; Hiroyuki Nomura and Daisuke Aoki, Keio University; Fumitoshi Terauchi, Tokyo Medical University, Tokyo; Takayuki Enomoto and Koji Nishino, Niigata University, Niigata; Eriko Aotani, Kanagawa Academy of Science and Technology; Nao Suzuki, St Marianna University, Kanagawa; Nobuo Yaegashi, Tohoku University, Miyagi; Kiyoko Kato, Kyushu University, Fukuoka; Hiroyuki Yoshikawa, University of Tsukuba, Ibaraki; Yoshihito Yokoyama, Hirosaki University, Aomori; Keiichi Fujiwara, Saitama Medical University International Medical Center, Saitama, Japan; Jae-Weon Kim, Seoul National University; Byoung-Gie Kim, Sungkyunkwan University, Seoul, South Korea; Sandro Pignata, Istituto Nazionale Tumori di Napoli, Naples, Italy; Jerome Alexandre, Hôpital Hôtel-Dieu, Montreal, Quebec, Canada; and John Green, University of Liverpool, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.9010DOI Listing
August 2016

Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer.

Oncology 2016 17;90(1):29-35. Epub 2015 Oct 17.

Department of Urology and Gynecology, Istituto Nazionale Tumori x2018;Fondazione G. Pascale', IRCCS, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000441226DOI Listing
July 2016

Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?

Cancer Treat Rev 2016 Jul 18;48:61-8. Epub 2016 Jun 18.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Via Mariano Semmola 52, 80131 Naples, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.06.008DOI Listing
July 2016

Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives.

Crit Rev Oncol Hematol 2016 Jan 10;97:335-48. Epub 2015 Aug 10.

Policlinico Universitario A. Gemelli, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.08.017DOI Listing
January 2016

Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma.

J Clin Oncol 2015 Nov 15;33(31):3576-82. Epub 2015 Jun 15.

Amit M. Oza, Princess Margaret Cancer Centre, Toronto, ON, Canada; Sandro Pignata, Istituto Nazionale Tumori "Fondazione G Pascale"-Istituto Di Ricovero e Cura a Carattere Scientifico, Naples, Italy; Andres Poveda, Instituto Valenciano de Oncologia, Valencia, Spain; Mary McCormack, University College Hospital, London; Andrew Clamp, Institute of Cancer Sciences-University of Manchester and the Christie National Health Service Foundation Trust, Manchester, United Kingdom; Benjamin Schwartz, Island Gynecologic Oncology, Brightwaters, NY; Jonathan Cheng, Xiaoyun Li, and Kristy Campbell, Merck, Kenilworth, NJ; and Pierre Dodion and Frank G. Haluska, ARIAD Pharmaceuticals, Cambridge, MA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/31/3576.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.8871
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.8871DOI Listing
November 2015

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.

Sci Rep 2015 May 28;5:10357. Epub 2015 May 28.

Molecular Immunology and Immuneregulation, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" IRCCS-ITALIA. Via Mariano Semmola 80131, Naples, Italy.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/srep10357
Publisher Site
http://dx.doi.org/10.1038/srep10357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650662PMC
May 2015

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

Cancer Treat Rev 2015 Feb 23;41(2):136-43. Epub 2014 Dec 23.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Via Mariano Semmola, 52, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.12.003DOI Listing
February 2015

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S9-13

*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000257DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S96-101

*Jichi Medical University, Shimono-City, Japan and GOTIC; †Saitama Cancer Center, Saitama-City, Japan and GOTIC; ‡University of Arizona, Phoenix, AZ and GOG; §Centre Leon Berard, Lyon, France and GINECO; ∥Hospices Civils de Lyon, Lyon, France and GINECO; ¶The Canberra Hospital, Canberra, Australia and ANZGOG; #Seoul National University College of Medicine, Seoul, Korea and KGOG; **Universtatsklinikum Hamburg-Eppendorf, Hamburg, Germany and AGO; ††Walter Reed National Military Medical Center, Bethesda, MD and GOG; ‡‡Istituto Nazionale Tumori "Fondazione G. Pascale" - IRCCS, Milan, Italy and MITO; and §§Saitama Medical University International Medical Center, Hidaka-City, Japan and GOTIC.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000263DOI Listing
November 2014

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

J Clin Oncol 2014 Oct 15;32(30):3374-82. Epub 2014 Sep 15.

Andreas du Bois, Rainer Kimmig, Klaus H. Baumann, Christian Kurzeder, Ulrich Canzler, Philipp Harter, AGO Ovarian Cancer Study Group (AGO); Andreas du Bois, Christian Kurzeder, Philipp Harter, Kliniken Essen Mitte; Rainer Kimmig, West German Tumor Center, University of Duisburg-Essen, Essen; Joern Rau, Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg; Klaus H. Baumann, University of Marburg, Marburg; Ulrich Canzler, University Hospitals Carl Gustav Carus, Dresden, Germany; Anne Floquet, Isabelle Ray-Coquard, Marie-Ange Mouret-Reynier, Anne Lesoin, Eric Pujade-Lauraine, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers Ovariens; Anne Floquet, Institut Bergonié, Bordeaux; Isabelle Ray-Coquard, Centre Léon Bérard, Lyon; Marie-Ange Mouret-Reynier, Centre Jean Perrin, Clermont-Ferrand; Anne Lesoin, Centre Oscar Lambret, Lille; Eric Pujade-Lauraine, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, Paris, France; Jae-Weon Kim, Jae-Hoon Kim, Korean Gynecologic Oncology Group; Jae-Weon Kim, Seoul National University; Jae-Hoon Kim, Yonsei University; Byoung-Gie Kim, Samsung Medical Center, Seoul, Republic of Korea; Josep M. del Campo, Ivan Diaz-Padilla, Spanish Ovarian Cancer Research Group; Josep M. del Campo, Vall d'Hebron University Hospital, Barcelona; Ivan Diaz-Padilla, Centro Integral Oncologico Clara Campal, HM Hospitales, Madrid, Spain; Michael Friedlander, Paul Vasey, Australian and New Zealand Gynecological Oncology Group; Michael Friedlander, The Prince of Wales Clinical School University of New South Wales, Randwick, New South Wales; Paul Vasey, Wesley Medical Centre, Auchenflower, Queensland, Australia; Sandro Pignata, Giovanni Scambia, Multicenter Italian Trials in Ovarian Cancer; Sandro Pignata, Istituto Nazionale Tumori Fondazione G. Pascale, Naples; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan-Bicocca and European Institute of Oncology, Milan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7348DOI Listing
October 2014

Surveillance policy for stage IA malignant ovarian germ cell tumors in children and young adults.

J Clin Oncol 2014 Sep 28;32(25):2814-5. Epub 2014 Jul 28.

Istituto Nazionale Tumori Fondazione G. Pascale, Istituto Di Ricovero e Cura a Carattere Scientifico, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.9617DOI Listing
September 2014

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer - authors' reply.

Lancet Oncol 2014 Jun;15(7):e250-1

Unità Sperimentazioni Cliniche, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70219-0DOI Listing
June 2014

New biological treatments for gynecological tumors: focus on angiogenesis.

Expert Opin Biol Ther 2014 Mar 6;14(3):337-46. Epub 2014 Jan 6.

Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale", IRCCS, Clinical Trials Unit , Via M. Semmola, 80131, Napoli , Italy +39 081 593 571 ; +39 081 770 2938 ; ,

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.2014.87
Publisher Site
http://dx.doi.org/10.1517/14712598.2014.873401DOI Listing
March 2014

Laparoscopic treatment of a Yolk Sac Tumor: case report and literature review.

Transl Med UniSa 2013 Sep 2;7:1-5. Epub 2013 Sep 2.

Department of Gynaecology and Obstetrics, University of Salerno, Salerno, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829784PMC
September 2013

Testicular and testicular adnexa tumors in the elderly.

Anticancer Drugs 2013 Mar;24(3):228-36

Pathology Unit, National Cancer Institute, IRCCS - Fondazione Giovanni Pascale, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e32835a3598DOI Listing
March 2013

Olaparib, PARP1 inhibitor in ovarian cancer.

Expert Opin Investig Drugs 2012 Oct 13;21(10):1575-84. Epub 2012 Jul 13.

Sapienza University of Rome, Department of Gynecologic-Obstetrical and Urologic Sciences, Viale del Policlinico, 155 - 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.2012.70
Publisher Site
http://dx.doi.org/10.1517/13543784.2012.707189DOI Listing
October 2012

Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.

Crit Rev Oncol Hematol 2012 Jul 4;83(1):35-46. Epub 2011 Nov 4.

Department of Gynaecology and Obstetrics, Sapienza University of Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2011.09.006DOI Listing
July 2012

Chemotherapy in epithelial ovarian cancer.

Cancer Lett 2011 Apr 24;303(2):73-83. Epub 2011 Feb 24.

Division of Medical Oncology, Department of Urology and Gynecology, National Cancer Institute of Naples, Via Mariano Semmola, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2011.01.026DOI Listing
April 2011